Serum antibodies to Escherichia coli in breast-fed and bottle-fed infants

H Ogura1

  • 1Department of Pediatrics, Kochi Medical School, Japan.

Acta Medica Okayama
|August 1, 1987
PubMed

Insights

Antibodies against Escherichia coli are high in early human milk but absent in healthy breast-fed infants. Bottle-fed infants and those post-weaning show detectable E. coli antibodies, suggesting passive immunity is limited.

Area of Science:

  • Immunology
  • Pediatrics
  • Microbiology

Background:

  • Human milk contains antibodies crucial for infant immunity.
  • Escherichia coli (E. coli) is a common bacterium affecting infants.
  • Understanding infant immune responses to E. coli is vital for health.

Purpose of the Study:

  • To investigate the presence and levels of antibodies against Escherichia coli (E. coli) in human milk and infant sera.
  • To compare antibody titers in breast-fed, bottle-fed, and post-weaning infants.
  • To assess the role of maternal antibodies in protecting infants against E. coli.

Main Methods:

  • Passive hemagglutination method was used to measure antibody titers.
  • Samples were collected from human milk and infant sera.
  • Infant groups included breast-fed, bottle-fed, and post-weaning infants.

Main Results:

  • High E. coli antibody titers were found in human milk during the first four days postpartum, decreasing rapidly thereafter.
  • Healthy breast-fed infants showed no detectable serum antibodies against E. coli.
  • A breast-fed infant with an E. coli abscess had detectable antibodies, as did 4/6 bottle-fed infants and all 9 post-weaning infants.

Conclusions:

  • Maternal antibodies in early human milk may provide temporary protection against E. coli.
  • Infants rely on their own immune systems to develop antibodies against E. coli after the initial doğum period.
  • Bottle-feeding and post-weaning stages are associated with the development of infant serum antibodies against E. coli.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...